A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE

Autor: DANNER, SA, CARR, A, LEONARD, JM, LEHMAN, LM, GUDIOL, F, GONZALES, J, RAVENTOS, A, RUBIO, R, BOUZA, E, PINTADO, Olga, AGUADO, AG, DELOMAS, JG, DELGADO, R, BORLEFFS, JCC, HSU, A, VALDES, JM, BOUCHER, CAB, COOPER, DA, GIMENO, C, CLOTET, B, TOR, J, FERRER, E, MARTINEZ, PL, MORENO, S, ZANCADA, G, ALCAMI, J, NORIEGA, AR, PULIDO, F, GLASSMAN, HN

Publikováno v: Recercat. Dipósit de la Recerca de Catalunya
instname
New England Journal of Medicine, 333(23), 1528-1533. MASSACHUSETTS MEDICAL SOC
Dipòsit Digital de la UB
Universidad de Barcelona
Danner, S A, Carr, A, Leonard, J M, Lehman, L M, Gudiol, F, Gonzales, J, Raventos, A, Rubio, R, Bouza, E, Pintado, V, Aguado, A G, Garcia de Lomas, J, Delgado, R, Borleffs, J C C, Hsu, A, Valdes, J M, Boucher, C A B & Cooper, D A 1995, ' A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of hiv-1 protease ', New England Journal of Medicine, vol. 333, no. 23, pp. 1528-1534 . https://doi.org/10.1056/NEJM199512073332303
New England Journal of Medicine, 333(23), 1528-1534. Massachussetts Medical Society

Background. Reverse-transcriptase inhibitors have only moderate clinical efficacy against the human immunodeficiency virus type 1 (HIV-1). Ritonavir is an inhibitor of HIV-1 pretease with potent in vitro anti-HIV properties and good oral bioavailabil

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60c0eb9dac655acaa35a14698702748c
https://doi.org/10.1056/NEJM199512073332303

Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

Autor: Costagliola, D, Dabis, F, Monforte, AD, de Wolf, F, Egger, M, Fatkenheuer, G, Gill, J, Hogg, R, Justice, A, Ledergerber, B, Lundgren, J, May, M, Phillips, A, Reiss, P, Sabin, C, Staszewski, S, Sterne, J, Weller, H.H., Beckthold, B, Yip, B, Dauer, B, Fusco, J, Grabar, S, Lanoy, E, Junghans, C, Lavignolle, V., van Leth, F, Pereira, E, Pezzotti, P, Schmeisser, N, Billaud, E, Boue, F, Duval, J., Duvivier, C, Enel, P, Fournier, S, Gasnault, J, Gaud, C, Gilquin, J, Khuong, MA, Lang, JM, Mary-Krause, M, Sprenger, HG, Doedens, Rienus, Scholvinck, EH, Borleffs, JCC

Publikováno v: Clinical Infectious Diseases, 41(12), 1772-1782. Oxford University Press

Background. We obtained estimates of the incidence of tuberculosis (TB) among patients receiving HAART and identified determinants of the incidence. Methods. We analyzed the incidence of TB during the first 3 years after initiation of HAART among 17,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::c7f8e30e5012ca076f9d896251482773
https://research.rug.nl/en/publications/b5b08a28-ede2-47cd-918d-548320cdc7ec

Is the combination of hepatitis and indinavir potentially dangerous?

Autor: Jeurissen, FJF, Schneider, MME, Borleffs, JCC

Publikováno v: Aids, 12(4), 441-442. LIPPINCOTT WILLIAMS & WILKINS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::76cc15b1494bc02f675f3be233f5759a
https://research.rug.nl/en/publications/e5768fdb-dc93-4b79-b506-e805c4048602

Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults

Autor: Bodsworth, NJ, Boag, F, Burdge, D, Genereux, M, Borleffs, JCC, Evans, BA, Modai, J, Colebunders, R, Thomas, M, DeHertogh, D, Pacelli, L, Thomis, J, Knight, E.L., McNulty, AM, Delaney, C, VanHove, D, Sacks, S, Gage, L, McLeod, A, DiazMitoma, F, Fong, J, MacFadden, D, Martel, A, Rachlis, A, Salit, [No Value], Shafran, S, Szabo, J, Toma, E, Deschenes, L, Gill, J, Lalonde, R, Kaufhold, R, Molina, JM, Dellamonica, P, Rozenbaum, W, Kolsters, FP, Meenhorst, PL, Danner, S, Sprenger, HG, EllisPegler, RB, Moragas, J, Moyle, G, Colman, J, Parnell, A, McLean, KA, Holmes, DA, Kitchen, C.M.R., Linde, A, Dahl, H, Dwyer, D

Publikováno v: Journal of infectious diseases, 176(1), 103-111. Oxford University Press

The clinical efficacy and safety of sorivudine as treatment for acute cutaneous tester in human immunodeficiency virus-infected adults was compared with that of acyclovir in a double-blinded randomized study, A total of 125 patients with laboratory-c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::aad7951d0991c536543f35083bdfd5aa
https://research.rug.nl/en/publications/f54554eb-eab2-4843-bbf6-157d5a0c4c56

MONITORING THE GROWING WORKLOAD FOR THE TREATMENT OF PEOPLE WITH AIDS (PWA) IN A UNIVERSITY HOSPITAL, 1987-1990

Autor: DIJKGRAAF, MGW, VANWEELDEREN, J, VREHEN, HM, JAGER, JC, BORLEFFS, JCC

Publikováno v: Aids, 6(4):1992200, 433-435. LIPPINCOTT WILLIAMS & WILKINS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::6efadf0f94871710c01abdeda7b7420e
https://research.rug.nl/en/publications/cc85582e-b652-4cf2-ba41-8e0034890e81